| 000 | 01820 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515094403.0 | ||
| 264 | 0 | _c20080501 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2008.02841.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmonts, M | |
| 245 | 0 | 0 |
_aThrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _c02 2008 |
||
| 300 |
_a268-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aCarboxypeptidase B2 _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDisseminated Intravascular Coagulation _xblood |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningococcal Infections _xblood |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aNeisseria meningitidis _xclassification |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aSerotyping |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aShock, Septic _xblood |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _ade Bruijne, E L E | |
| 700 | 1 | _aGuimarães, A H C | |
| 700 | 1 | _aDeclerck, P J | |
| 700 | 1 | _aLeebeek, F W G | |
| 700 | 1 | _ade Maat, M P M | |
| 700 | 1 | _aRijken, D C | |
| 700 | 1 | _aHazelzet, J A | |
| 700 | 1 | _aGils, A | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 6 _gno. 2 _gp. 268-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2008.02841.x _zAvailable from publisher's website |
| 999 |
_c17537645 _d17537645 |
||